Try our beta test site
84 studies found for:    exendin
Show Display Options
Rank Status Study
1 Recruiting 68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis
Conditions: Insulinoma;   Nesidioblastosis
Intervention: Drug: 68Ga-NOTA-exendin-4
2 Recruiting Effect of Exendin-(9-39) On Glucose Requirements To Maintain Euglycemia
Condition: Congenital Hyperinsulinism
Interventions: Drug: exendin-(9-39);   Other: placebo
3 Completed
Has Results
Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism
Condition: Congenital Hyperinsulinism
Interventions: Drug: Exendin-(9-39);   Other: Vehicle
4 Active, not recruiting A Dose-response of the Effects of Exendin-9,39 on GI Symptoms and Food Intake
Conditions: Obesity;   Diabetes;   Roux-en-Y Gastric Bypass
Interventions: Drug: Exendin-9,39;   Other: Saline
5 Completed Effects of Exendin(9-39) on Gastroduodenal Motility
Conditions: Digestive Physiology;   Gastrointestinal Motility;   Gastrointestinal Hormones;   Glucagon-like Peptide 1;   Exendin (9-39)
Interventions: Drug: exendin(9-39)amide;   Drug: atropine
6 Active, not recruiting Effect of Gelofusine on GLP1-receptor Imaging
Conditions: Diabetes Mellitus, Non-Insulin-Dependent;   Diabetes Mellitus
Interventions: Drug: Gelofusine;   Radiation: 111In-exendin 4 SPECT/CT;   Drug: Placebo
7 Completed A Pilot Clinical Trial of Exendin-4 in Alzheimer's Disease
Conditions: Alzheimer's Disease;   Mild Cognitive Impairment
Intervention: Drug: Exendin-4 (Exenatide)
8 Completed Dose-response Study of Exendin-9,39 on Glucose Metabolism
Condition: Pancreatic Effects of 9,39-Exendin and 9,36-GLP-1
Interventions: Drug: saline infusion;   Drug: GLP-1-9,36 infusion;   Drug: Exendin-9,39 at low dose;   Drug: Exendin-9,39 at high dose
9 Completed Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in Humans
Condition: Hyperglycemia
Interventions: Drug: GLP-1 control;   Drug: GLP-1 and Exendin(9-39) 300;   Drug: saline control;   Drug: GLP-1 and Exendin(9-39) 600;   Drug: GLP-1 and Exendin(9-39) 900;   Drug: GLP-1 and Exendin(9-39) 1200
10 Recruiting Efficacy, Tolerability and Pharmacokinetics of Subcutaneous Exendin (9-39) in Patients With Post Bariatric Hypoglycemia
Condition: Post Bariatric Hypoglycemia
Intervention: Drug: Exendin (9-39)
11 Completed Effect of Exendin-(9-39) on Fasting Adaptation and Protein Sensitivity
Condition: Congenital Hyperinsulinism
Interventions: Drug: Exendin-(9-39);   Drug: placebo
12 Not yet recruiting Exendin-9,39 and Satiety After Bariatric Surgery
Condition: Obesity
Interventions: Drug: Saline;   Drug: Exendin-9,39
13 Active, not recruiting Evaluation of Single Ascending Doses of Subcutaneous Exendin 9-39 in Patients With Post-Bariatric Hypoglycemia
Condition: Hyperinsulinemia Hypoglycemia
Intervention: Drug: Exendin (9-39)
14 Recruiting New Imaging Procedure for the Localisation of Insulinoma and Transplanted Islet Cells
Conditions: Endogenous Hyperinsulinaemic Hypoglycaemia;   Transplanted Islet Cells
Intervention: Other: Ga -exendin PET/CT, In- exendin SPECT/CT, MRI
15 Completed
Has Results
Role of Glucagon-Like Peptide-1 in Postprandial Hypoglycemia
Condition: Postprandial Hypoglycemia
Interventions: Drug: Exendin-(9-39);   Other: Vehicle
16 Completed Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients
Conditions: Hyperinsulinism;   Hypoglycemia;   Insulinoma
Intervention: Other: 111In-exendin-4 imaging
17 Recruiting Determinants of Diabetes Remission After Gastric Bypass Surgery
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Exendin9
18 Recruiting Visualizing Beta Cells After Bariatric Surgery
Condition: Type 2 Diabetes Mellitus
Intervention: Radiation: 68Ga-exendin PET/CT
19 Unknown  Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study
Condition: Parkinson's Disease
Intervention: Drug: Exenatide
20 Completed GLP-1 Receptor Targeting in Diabetic and Healthy Individuals
Condition: Type 1 Diabetes
Intervention: Other: radiolabeled Exendin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.